{
  "ptid_time": "016_S_4887_2012-11-19",
  "img_path": "/data/qiuhui/data/adni/images/016_S_4887/2012-11-19/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 47,165 mm³, 22.5% above the reference mean. With a Z-score of 0.54 (70.5th percentile), this represents normal volume ; whole brain volume measures 998,848 mm³, 7.5% below the reference mean. With a Z-score of -0.97 (16.6th percentile), this represents normal volume . ",
  "text_data": "Age is 73.8 years. Gender is Male. Education: 12 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary. MMSE: 26.0. MoCA: 20.0. Logical Memory: 2.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.63 SUVR (profound elevated); Amyloid beta: 818.30 pg/mL (normal ); Total tau: 216.50 pg/mL (normal ); Phosphorylated tau: 21.33 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "Reasoning: The patient shows normal brain volumes with slightly reduced whole brain volume but within normal range. The MMSE is borderline (26/30), and the MoCA is mildly impaired (20/30), suggesting cognitive deficits. However, biomarkers (Aβ, T-tau, P-tau) are normal, while AV45 (amyloid PET) is profoundly elevated, indicating amyloid pathology.  \nDiagnosis: **Mild Cognitive Impairment (MCI)**  \nConfidence: **Medium** (due to conflicting biomarker findings—normal CSF but elevated AV45—and borderline cognitive scores)",
  "timestamp": "2025-07-26T00:29:59.762081"
}